Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Int J Vitam Nutr Res ; 76(4): 194-9, 2006 Jul.
Article in English | MEDLINE | ID: mdl-17243082

ABSTRACT

Obesity is a chronic disease associated with important additional diseases, such as DM 2, that both reduce life quality and increase morbimortality from any cause. In the Western world, obesity is directly responsible for most deaths due to associated chronic disease. Therefore, substantial effort should be directed towards adequate primary prevention campaigns and policies, as well as towards an intensive and long-term multidisciplinary treatment of obesity, in an attempt to combat this threat to the health of a large part of our population.


Subject(s)
Diabetes Mellitus, Type 2/prevention & control , Obesity/prevention & control , Physical Examination/methods , Preventive Medicine/methods , Adult , Female , Humans , Male , Middle Aged , Obesity/epidemiology , Obesity/therapy , Prevalence , Spain/epidemiology
10.
Fertil Steril ; 30(4): 430-5, 1978 Oct.
Article in English | MEDLINE | ID: mdl-361442

ABSTRACT

Three male patients, diagnosed to have hypogonadotopic hypogonadism, were treated with intramuscular injections of 10 microgram of D-Trp6-luteinizing hormone-releasing hormone (D-Trp6-LH-RH) every 8 hours for more than 90 days (13 to 17 weeks). The gonadotropin and testosterone concentrations reached levels twice as great during the treatment as those measured previously and on one occasion increased 5-fold. Before treatment, the patients were clinically in grade 1 on Tanner's scale (Growth at Adolescence, Second Edition. Oxford, Blackwell Scientific Publications, 1962) but after treatment they advanced to grades 2 to 4. Testicular sizes before treatment were between 2 and 2 according to the scales of Waaler et al. (Acta Paediatr Scand [Suppl]249:1, 1974) and afterwards between 4 and 10. The penis of one of the patients grew 3 cm. The testicular biopsy after treatment showed significant increases in the number of Leydig and Sertoli cells. After treatment, spermatogonia were present in increased number, together with a much higher population of cells corresponding to additional stages of development (spermatids). We are of the opinion that therapy with D-Trp6-LH-RH may be beneficial for such patients.


Subject(s)
Gonadotropin-Releasing Hormone/therapeutic use , Hormones/therapeutic use , Hypogonadism/drug therapy , Follicle Stimulating Hormone/blood , Humans , Hypogonadism/pathology , Luteinizing Hormone/blood , Male , Spermatogenesis , Testis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...